Prevention of mother-to-child transmission of HIV-1 through breast-feeding: Past, present, and future

Journal of Infectious Diseases

Volumn 189, Issue 12, 2004, Pages 2149-2153

  Bulterys, Marc ^a   Fowler, Mary Glenn ^a   Van Rompay, Koen K ^b   Kourtis, Athena P ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; EFAVIRENZ; ETRAVIRINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LAMIVUDINE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; ZIDOVUDINE;

ACTIVE IMMUNIZATION; ANTIBIOTIC RESISTANCE; ARTIFICIAL MILK; BREAST FEEDING; CELL COUNT; CELLULAR IMMUNITY; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; INFANT MORTALITY; INFECTION PREVENTION; LACTATION; LYMPHOCYTE DEPLETION; META ANALYSIS; MOTHER CHILD RELATION; NOTE; PASSIVE IMMUNIZATION; PERINATAL PERIOD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; SIDE EFFECT; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; BREAST FEEDING; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; MILK, HUMAN; PREGNANCY;

EID: 2942627673     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/420835     Document Type: Note

References (66)

1. The Breastfeeding and HIV International Transmission Study (BHITS) Group. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis 2004; 189:2154-66 (in this issue).
2. Ferrantelli F, Rasmussen RA, Buckley KA, et al. Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immundeficiency virus by human anti-HIV monoclonal antibodies. J Infect Dis 2004; 189:2167-73 (in this issue).
3. Baba TW, Liska V, Hofmann-Lehmann R, et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nature Med 2000; 6:200-6.
4. Ferrantelli F, Hofmann-Lehmann R, Rasmussen RA, et al. Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques. AIDS 2003; 17:301-9.
5. Hofmann-Lehmann R, Vlasak J, Rasmussen RA, et al. Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge. J Virol 2001; 75:7470-80.
6. Van Rompay KK, Berardi CJ, Dillard-Telm S, et al. Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J Infect Dis 1998; 177: 1247-59.
7. Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 2000; 283:1167-74.
8. Newell, ML. Mechanisms and timing of mother-to-child transmission of HIV-1. AIDS 1998; 12:831-7.
9. Kourtis AP, Bulterys M, Nesheim SR, Lee FK. Timing of HIV transmission from mother to infant. JAMA 2001; 285:709-12.
10. Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992; 340:585-8.
11. Van De Perre P, Simonon A, Hitimana DG, et al. Infective and anti-infective properties of breastmilk from HIV-infected women. Lancet 1993; 341:914-8.
12. Miotti PG, Taha TE, Kumwenda NI, et al. HIV transmission through breastfeeding: a study in Malawi. JAMA 1999; 282:744-9.
13. Kourtis AP, Butera S, Ibegbu C, Belec L, Duerr A. Breast milk and HIV-1: a vector of transmission or vehicle of protection? Lancet Infect Dis 2003; 3:786-93.
14. Van de Perre P, Lepage P, Homsy J, Dabis F. Mother-to-infant transmission of human immunodeficiency virus by breast milk: presumed innocent or presumed guilty? Clin Infect Dis 1992; 15:502-7.
15. Fowler MG, Newell ML. Breast-feeding and HIV-1 transmission in resource-limited settings. J Acquir Immune Defic Syndr 2002; 30: 230-9.
16. Bertolli J, Hu DJ, Nieburg P, Macalalad A, Simonds RJ. Decision analysis to guide choice of interventions to reduce mother-to-child transmission of HIV. AIDS 2003; 17:1-10.
17. Jelliffe DB, Stanfield JP. Diseases of children in the subtropics and tropics. Edward Arnold Publishers Ltd., 1978:168-95.
18. Lepage P, Munyakazi C, Hennart P. Breast feeding and hospital mortality in children in Rwanda. Lancet 1981; 2:409-41.
19. Habicht JP, Da Vanzo J, Butz WP. Does breast-feeding really save lives or are apparent benefits due to biases? Am J Epidemiol 1986; 123: 279-90.
20. World Health Organization Collaborative Study Team on the Role of Breast-feeding on the Prevention of Infant Mortality. Effect of breast-feeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. Lancet 2000; 355:451-5.
21. Jelliffe DB, Jelliffe EF. Human milk in the modern world. Oxford: Oxford University Press, 1977.
22. Thapa S, Short RV, Potts M. Breastfeeding, birth spacing, and their effects on child survival. Nature 1988; 335:679-82.
23. Read JS. American Academy of Pediatrics Committee on Pediatric AIDS. Human milk, breastfeeding, and transmission of human immunodeficiency virus type 1 in the United States. Pediatrics 2003; 112:1196-205.
24. Lewis P, Nduati R, Kreiss JK, et al. Cell-free human immunodeficiency virus type 1 in breastmilk. J Infect Dis 1998; 177:34-9.
25. Nolan ML, Greenberg AE, Fowler MG. A review of clinical trials to prevent mother-to-child HIV-1 transmission in Africa and inform rational intervention strategies. AIDS 2002; 16:1-9.
26. John-Stewart G, Mbori-Ngacha D, Ekpini R, et al. Breast-feeding and transmission of HIV-1. J Acquir Immune Defic Syndr 2004; 35:196-202.
27. Coutsoudis A, Pillay K, Kuhn L, et al. Methods of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS 2001; 15:379-87.
28. Rollins N, Meda N, Becquet R, et al. Preventing postnatal transmission of HIV-1 through breast-feeding: modifying infant feeding practices. J Acquir Immune Defic Syndr 2004; 35:188-95.
29. Kiarie JN, Richardson BA, Mbori-Ngacha D, Nduati RW, John-Stewart GC. Infant feeding practices of women in a perinatal HIV-1 prevention study in Nairobi, Kenya. J Acquir Immune Defic Syndr 2004; 35:75-81.
30. Fultz PN. HIV-1 superinfections: omens for vaccine efficacy? AIDS 2004; 18:115-9.
31. Gottlieb GS, Nickle DC, Jensen MA, et al. Dual HIV-1 infection associated with rapid disease progression. Lancet 2004; 363:619-22.
32. Renjifo B, Gilbert P, Chaplin B, et al. Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 region. AIDS 1999; 13:1613-21.
33. Bulterys M, Chao A, Dushimimana A, et al. Multiple sexual partners and mother-to-child transmission of HIV-1. AIDS 1993; 7:1639-45.
34. Feinberg MB, Moore JP, AIDS vaccine models: challenging challenge viruses. Nature Med 2002; 8:207-10.
35. Montefiori DC, Reimann KA, Wyand MS, et al. Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1. J Virol 1998; 72:3427-31.
36. Safrit JT, Ruprecht R, Ferrantelli F, et al. Immunoprophylaxis to prevent mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr 2004; 35:169-77.
37. Van Rompay KK, Greenier JL, Cole KS, et al. Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251. J Virol 2003; 77:179-90.
38. Rasmussen RA, Hofmann-Lehman R, Montefiore DC, et al. DNA prime/protein boost vaccine strategy in neonatal macaques against simian human immunodeficiency virus. J Med Primatol 2002; 31:40-60.
39. Marthas M, Van Rompay K, Earl P, Tartaglia J. Neonatal vaccination provides long-term protection of macaques against oral SIV exposure [abstract 271]. In: Program and abstracts of the 11th Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, VA: Foundation for Retrovirology and Human Health, 2004:165.
40. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomized controlled trial. Lancet 1999; 353:773-80.
41. Wiktor SZ, Ekpini E, Karon JM, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomized trial. Lancet 1999; 353:781-5.
42. Dabis F, Msellati P, Meda N, et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. Lancet 1999; 353:786-92.
43. Guay L, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial. Lancet 1999; 354:795-802.
44. Lallemant M, Jourdain G, Le Coeur S, et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of HIV-1. N Engl J Med 2000; 343:982-91.
45. The Petra study team. Efficacy of the three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa and Uganda (Petra Study): a randomized, double-blind, placebo-controlled trial. Lancet 2002; 359:1178-86.
46. Chaisilwattana P, Chokephaibulkit K, Chalermchockcharoenkit A, et al. Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand. Clin Infect Dis 2002; 35:1405-13.
47. Jackson B, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomized trial. Lancet 2003; 362: 859-67.
48. Moodley D, Moodley J, Coovadia H, et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 2003; 187:725-35.
49. Mofenson LM. Tale of two epidemics - the continuing challenge of preventing mother-to-child transmission of human immunodeficiency virus. J Infect Dis 2003; 187:721-4.
50. Lallemant M, Jourdain G, Le Coeur S, et al. A randomized, double-blind trial assessing the efficacy of single-dose perinatal nevirapine added to a standard zidovudine regimen for the prevention of mother-to-child transmission of HIV-1 in Thailand [abstract 40LB]. In: Program and abstracts of the 11th Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, VA: Foundation for Retrovirology and Human Health, 2004:91.
51. Dabis F, Ekouevi DK, Rouet F, et al. Effectiveness of a short course of zidovudine + lamivudine and peripartum nevirapine to prevent HIV-1 mother-to-child transmission: the ANRS DITRAME Plus trial, Abidjan, Côte d'Ivoire [abstract 219]. Antivir Ther 2003; 8 (Suppl 1):S236-7.
52. Leroy V, Karon JM, Alioum A, et al. 24-month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS 2002; 16: 631-41.
53. Gaillard P, Fowler MG, Dabis F, et al. Use of antiretroviral drugs to prevent HIV-1 transmission through breastfeeding: from animal studies to randomized clinical trials. J Acquir Immune Defic Syndr 2004; 35:178-87.
54. World Health Organization (WHO). Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. Geneva: WHO, December 2003. Available at: http://www.who.int/3by5/ publications/documents/arv_guidelines/en/. Accessed 26 February 2004.
55. Weidle PJ, Mastro TD, Grant AD, Nkengasong I, Macharia D. HIV/AIDS treatment and HIV vaccines for Africa. Lancet 2002; 359:2261-7.
56. Jong-Wook L. Global health improvements and WHO: shaping the future. Lancet 2003; 362:2083-8.
57. Fowler MG, Mofenson L, McConnell M. The interface of perinatal HIV prevention, antiretroviral drug resistance, and antiretroviral treatment: what do we really know? J Acquir Immune Defic Syndr 2003; 34:308-11.
58. Eshleman SH, Mracna M, Guay L, et al. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS 2001; 15:1951-7.
59. Chalermchokcharoenkit A, Asavapiriyanont S, Teeraratkul A, et al. Combination short-course zidovudine plus 2-dose nevirapine for prevention of mother-to-child HIV-1 transmission: safety, tolerance, transmission, and resistance results [abstract 96]. In: Program and abstracts of the 11th Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, VA: Foundation for Retrovirology and Human Health, 2004:111.
60. Jourdain G, Ngo-Giang-Huong N, Tungyai P, et al. Exposure to intrapartum single-dose nevirapine and subsequent maternal 6-month response to NNRTI-based regimens [abstract 41LB]. In: Program and abstracts of the 11th Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, VA: Foundation for Retrovirology and Human Health, 2004:92.
61. Abrams EJ. Maternal and infant treatment strategies for preventing mother-to-child HIV transmission [abstract 42]. In: Program and abstracts of the 11th Conference on Retroviruses and Opportunistic Infections (San Francisco). Alexandria, VA: Foundation for Retrovirology and Human Health, 2004:92.
62. Gazzard BG, Pozniak AL, Rosenbaum W, et al. An open-label assessment of TMC 125-a new, next-generation NNRTI, for 7 days in HIV-1 infected individuals with NNRTI resistance. AIDS 2003; 17:F49-54.
63. Van Rompay KK, McChesney MB, Aguirre NL, Schmidt KA, Bischofberger N, Marthas ML. Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection. J Infect Dis 2001; 184:429-38.
64. Gallant JE, Deresinski S. Tenofovir disoproxil fumarate. Clin Infect Dis 2003; 37:944-50.
65. Taha TE, Kumwenda N, Gibbons A, et al. Short postexposure prophylaxis in newborn infants to reduce mother-to-child transmission of HIV-1: NVAZ randomized clinical trial. Lancet 2003; 362:1171-7.
66. Safrit JT. HIV vaccines in infants and children: past trials, present plans and future perspectives. Curr Mol Med 2003; 3:303-12.